首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Anatomical Applicability of Endovascular Aneurysm Sealing Techniques in a Consecutive Cohort of Fenestrated Endovascular Aneurysm Repairs
【24h】

Anatomical Applicability of Endovascular Aneurysm Sealing Techniques in a Consecutive Cohort of Fenestrated Endovascular Aneurysm Repairs

机译:血管内动脉瘤密封技术的解剖学适用性在连续血管内动脉瘤修理中的连续群组中

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: To determine how many endovascular aneurysm sealing (EVAS) procedures with/without off-label use of chimneys (ChEVAS) could have been performed in a cohort of patients who had undergone fenestrated endovascular aneurysm repair (FEVAR). Methods: Sixty patients (median age 76.3 years; 54 men) who underwent FEVAR in our institution between 2013 and 2015 were selected for the study. The median aneurysm diameter was 62.0 mm (interquartile range 59.3, 69.0). Preoperative computed tomography angiograms (CTA) were anonymized and sent to 2 physicians with experience of more than 40 ChEVAS interventions. These ChEVAS planners were blinded to the study purpose and asked to agree upon an EVAS/ChEVAS plan. The primary outcome was the percentage of the FEVAR patients in whom an EVAS/ChEVAS was technically possible. The secondary outcomes were a comparison of seal zones, number of target vessels, and device cost. Results: An EVAS-based intervention would have been technically possible in 56 (93.3%) of the FEVAR patients. The median proximal aortic seal zone was significantly more distal in the EVAS/ChEVAS procedures vs the FEVAR cases (zone 8 vs zone 7, p < 0.001) and fewer target vessels were involved (median 2 vs 3, p < 0.001). The cost of the EVAS/ChEVAS device was 66% of the FEVAR device. Planners would not currently advocate an EVAS-based intervention in 43 (76.8%) of these 56 patients due to concerns regarding the risk of migration associated with the lumen thrombus ratios observed. Conclusion: EVAS is technically feasible in the majority of patients undergoing FEVAR in our institution but currently advocated in only 23.2%. The seal zone was more distal, fewer target vessels were involved, and the device cost was lower in the planned EVAS/ChEVAS interventions.
机译:目的:确定在一组接受开窗血管内动脉瘤修补术(FEVAR)的患者中,可以进行多少次血管内动脉瘤封堵(EVAS)手术,包括/不包括标签外使用烟囱(ChEVAS)。方法:选择2013年至2015年间在我院接受FEVAR治疗的60名患者(中位年龄76.3岁;54名男性)进行研究。动脉瘤直径中位数为62.0mm(四分位间距为59.3,69.0)。术前CT血管造影(CTA)匿名,并发送给2名有40多次ChEVAS干预经验的医生。这些ChEVAS规划者对研究目的视而不见,要求他们就EVAS/ChEVAS计划达成一致。主要结果是技术上可以进行EVAS/ChEVAS的FEVAR患者的百分比。次要结果是比较密封区、靶血管数量和设备成本。结果:在56例(93.3%)FEVAR患者中,基于EVAS的干预在技术上是可行的。EVAS/ChEVAS手术组与FEVAR组相比,近端主动脉正中密封区的远端明显更远(第8区与第7区,p<0.001),涉及的靶血管更少(中位数2对3,p<0.001)。EVAS/ChEVAS设备的成本是FEVAR设备的66%。由于担心与观察到的管腔血栓比率相关的迁移风险,规划者目前不主张对这56名患者中的43名(76.8%)进行基于EVAS的干预。结论:EVAS在我院接受FEVAR治疗的大多数患者中在技术上是可行的,但目前只有23.2%的患者支持EVAS。在计划的EVAS/ChEVAS干预中,密封区更远,涉及的靶血管更少,设备成本更低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号